广州医药 ›› 2021, Vol. 52 ›› Issue (5): 88-91.DOI: 10.3969/j.issn.1000-8535.2021.05.019

• 论著 • 上一篇    下一篇

内镜黏膜下剥离术治疗结直肠高级别上皮内瘤变的临床研究

张维, 袁帅   

  1. 南方医科大学附属小榄医院消化科(中山 528415)
  • 收稿日期:2021-03-27 出版日期:2021-09-20 发布日期:2021-11-24
  • 通讯作者: 袁帅,E-mail:yuanshuaishuai888@126.com

Clinical study of endoscopic submucosal dissection for colorectal high-grade intraepithelial neoplasia

ZHANG Wei, YUAN Shuai   

  1. Department of Gastroenterology,Xiaolan Hospital Affiliated to Southern Medical University, Zhongshan 528415,China
  • Received:2021-03-27 Online:2021-09-20 Published:2021-11-24

摘要: 目的 探讨内镜黏膜下剥离术(ESD)治疗结直肠高级别上皮内瘤变(HGIN)的安全性及临床疗效。方法 回顾性分析2016年1月—2019年6月在南方医科大学附属小榄医院经肠镜活检诊断为结直肠HGIN并接受ESD治疗的56例患者的临床资料,记录每例病变的术后病理、整块切除率、治愈性切除率、手术并发症和随诊结果。结果 病灶平均直径为(2.28±0.76) cm。53例经ESD术完整切除,3例术中改用内镜下黏膜分片切除术切除,整块切除率为94.64% (53/56)。术后病理51例HGIN,2例HGIN伴黏膜内癌,2例浸润性癌,术前活检与术后病理总符合率为92.86%(52/56),治愈性切除率为96.43%(54/56)。术中出血发生率为89.29%(50/56),术后迟发性出血发生率为3.57%(2/56)。术中穿孔发生率为5.36%(3/56),无术后迟发性穿孔病例。中位随访期为17个月,期间共1例患者复发。结论 ESD术治疗结直肠HGIN安全有效,但需警惕浸润性癌的可能。ESD术具有较高的术中出血和穿孔的风险,术者需具备熟练的操作技术及处理手术并发症的经验。

关键词: 结直肠肿瘤, 高级别上皮内瘤变, 内镜黏膜下剥离术

Abstract: Objective To investigate the clinical efficacy and safety of endoscopic submucosal dissection (ESD) for colorectal high-grade intraepithelial neoplasia (HGIN). Methods Data of 29 patients diagnosed as colorectal HGIN and underwent endoscopic submucosal dissection (ESD) from January 2016 to June 2019 were retrospectively analyzed. Postoperative pathology, total en bloc resection rate, curative resection rate, complication and follow-up results were recorded. Results The mean diameter of the lesions was (2.28±0.76) cm. A total of 53 cases were successfully treated by ESD, 3 cases were changed using endoscopy piecemeal mucosal resection, the en bloc resection rate was 94.64% (53/56). Postoperative diagnosis confirmed 52 cases of HGIN, 2 cases of HGIN with intra-mucosal cancers and 2 case of invasive cancer,the overall consistency rate between preoperative biopsies and postoperative pathological diagnosis was 92.86% (52/56), the curative resection rate was 96.43% (54/56). The incidence of intro-operative bleeding and postoperative delayed bleeding was 89.29% (50/56) and 3.57% (2/56) respectively. The incidence of intro-operative perforation was 5.36% (3/56) and no delayed perforation occurred. The median follow-up period was 17 months and one case recurred. Conclusion ESD is a safe and effective treatment for colorectal HGIN, but invasive cancer must be cautioned. ESD has high risk of intro-operative bleeding and perforation, therefore, the surgeon must have skilled operation and treatment experience for complications.

Key words: colorectal neoplasms, high-grade intraepithelial neoplasia, endoscopic submucosal dissection